Skip to main content
. 2020 Dec 16;8(4):e121. doi: 10.15190/d.2020.18

Figure 1. Overview of host pathways and viral replication mechanisms of the repurposed therapeutic drugs undergoing clinical trial against COVID-19.

Figure 1

Drugs of both biological and chemical origins are shown along with a number of vaccines involved in repurposed applications in context of their respective pathways and mechanisms.